US4302386A
(en)
*
|
1978-08-25 |
1981-11-24 |
The Ohio State University |
Antigenic modification of polypeptides
|
US4105776A
(en)
*
|
1976-06-21 |
1978-08-08 |
E. R. Squibb & Sons, Inc. |
Proline derivatives and related compounds
|
US4316906A
(en)
*
|
1978-08-11 |
1982-02-23 |
E. R. Squibb & Sons, Inc. |
Mercaptoacyl derivatives of substituted prolines
|
IL58849A
(en)
*
|
1978-12-11 |
1983-03-31 |
Merck & Co Inc |
Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
|
US4231938A
(en)
*
|
1979-06-15 |
1980-11-04 |
Merck & Co., Inc. |
Hypocholesteremic fermentation products and process of preparation
|
US4508729A
(en)
*
|
1979-12-07 |
1985-04-02 |
Adir |
Substituted iminodiacids, their preparation and pharmaceutical compositions containing them
|
US4444784A
(en)
*
|
1980-08-05 |
1984-04-24 |
Merck & Co., Inc. |
Antihypercholesterolemic compounds
|
DK149080C
(da)
*
|
1980-06-06 |
1986-07-28 |
Sankyo Co |
Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre
|
US4344949A
(en)
*
|
1980-10-03 |
1982-08-17 |
Warner-Lambert Company |
Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
|
ZA817261B
(en)
*
|
1980-10-23 |
1982-09-29 |
Schering Corp |
Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
|
US4337201A
(en)
*
|
1980-12-04 |
1982-06-29 |
E. R. Squibb & Sons, Inc. |
Phosphinylalkanoyl substituted prolines
|
US4410520A
(en)
*
|
1981-11-09 |
1983-10-18 |
Ciba-Geigy Corporation |
3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
|
GB2128984B
(en)
*
|
1982-05-12 |
1985-05-22 |
Hoffmann La Roche |
Diaza-bicyclic compounds
|
US4739073A
(en)
*
|
1983-11-04 |
1988-04-19 |
Sandoz Pharmaceuticals Corp. |
Intermediates in the synthesis of indole analogs of mevalonolactone and derivatives thereof
|
US4780401A
(en)
*
|
1984-04-09 |
1988-10-25 |
Ciba-Geigy Corporation |
Novel monoclonal antibodies to human renin and hybridoma cells, processes for their preparation and their applications
|
US4845079A
(en)
*
|
1985-01-23 |
1989-07-04 |
Luly Jay R |
Peptidylaminodiols
|
US5066643A
(en)
*
|
1985-02-19 |
1991-11-19 |
Sandoz Ltd. |
Fluorine and chlorine statine or statone containing peptides and method of use
|
US5387413A
(en)
*
|
1985-06-14 |
1995-02-07 |
The Research Foundation Of State University Of New York |
Method of inhibiting thrombus formation by the 7E3 monoclonal antibody
|
US4894437A
(en)
*
|
1985-11-15 |
1990-01-16 |
The Upjohn Company |
Novel renin inhibiting polypeptide analogs containing S-aryl-D- or L- or DL-cysteinyl, 3-(arylthio)lactic acid or 3-(arylthio)alkyl moieties
|
US4885292A
(en)
*
|
1986-02-03 |
1989-12-05 |
E. R. Squibb & Sons, Inc. |
N-heterocyclic alcohol renin inhibitors
|
US4816463A
(en)
*
|
1986-04-01 |
1989-03-28 |
Warner-Lambert Company |
Substituted diimidazo [1,5-a: 4',5'-d]pyridines having antihypertensive activity
|
US4940727A
(en)
*
|
1986-06-23 |
1990-07-10 |
Merck & Co., Inc. |
Novel HMG-CoA reductase inhibitors
|
US5116870A
(en)
*
|
1986-06-23 |
1992-05-26 |
Merck & Co., Inc. |
HMG-CoA reductase inhibitors
|
US4772684A
(en)
*
|
1987-01-20 |
1988-09-20 |
Triton Biosciences, Inc. |
Peptides affecting blood pressure regulation
|
US4904646A
(en)
*
|
1987-05-22 |
1990-02-27 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing HMG-COA reductase inhibitors
|
US5017716A
(en)
*
|
1987-05-22 |
1991-05-21 |
E.R. Squibb & Sons, Inc. |
Phosphorous-containing HMG-CoA reductase inhibitors, new intermediates and method
|
US5091378A
(en)
*
|
1987-05-22 |
1992-02-25 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing HMG-CoA reductase inhibitors, new intermediates and method
|
US4997837A
(en)
*
|
1987-09-08 |
1991-03-05 |
Warner-Lambert Company |
6-(((substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
|
US4906624A
(en)
*
|
1987-09-08 |
1990-03-06 |
Warner-Lambert Company |
6-(((Substituted)pyridin-3-yl)alkyl)-and alkenyl)-tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
|
US4980283A
(en)
*
|
1987-10-01 |
1990-12-25 |
Merck & Co., Inc. |
Renin-inhibitory pepstatin phenyl derivatives
|
US5089471A
(en)
*
|
1987-10-01 |
1992-02-18 |
G. D. Searle & Co. |
Peptidyl beta-aminoacyl aminodiol carbamates as anti-hypertensive agents
|
US5034512A
(en)
*
|
1987-10-22 |
1991-07-23 |
Warner-Lambert Company |
Branched backbone renin inhibitors
|
US5063207A
(en)
*
|
1987-10-26 |
1991-11-05 |
Warner-Lambert Company |
Renin inhibitors, method for using them, and compositions containing them
|
US5055466A
(en)
*
|
1987-11-23 |
1991-10-08 |
E. R. Squibb & Sons, Inc. |
N-morpholino derivatives and their use as anti-hypertensive agents
|
US4929620A
(en)
*
|
1987-12-10 |
1990-05-29 |
Warner-Lambert Company |
5-pyrimidinyl-3,5-dihydroxy-6-heptenoic acid compounds useful as inhibitors of cholesterol biosynthesis
|
US4939143A
(en)
*
|
1987-12-21 |
1990-07-03 |
Rorer Pharmaceutical Corporation |
Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
|
US5001128A
(en)
*
|
1987-12-21 |
1991-03-19 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
HMG-COA reductase inhibitors
|
US4900754A
(en)
*
|
1987-12-21 |
1990-02-13 |
Rorer Pharmaceutical Corp. |
HMG-COA reductase inhibitors
|
US4994494A
(en)
*
|
1987-12-21 |
1991-02-19 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
HMG-COA reductase inhibitors
|
US5001144A
(en)
*
|
1987-12-21 |
1991-03-19 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
|
US5081127A
(en)
*
|
1988-01-07 |
1992-01-14 |
E. I. Du Pont De Nemours And Company |
Substituted 1,2,3-triazole angiotensin II antagonists
|
US4946864A
(en)
*
|
1988-02-01 |
1990-08-07 |
Merck & Co., Inc. |
Novel HMG-CoA reductase inhibitors
|
US5036054A
(en)
*
|
1988-02-11 |
1991-07-30 |
Warner-Lambert Company |
Renin inhibitors containing alpha-heteroatom amino acids
|
US5021453A
(en)
*
|
1988-03-02 |
1991-06-04 |
Merck & Co., Inc. |
3-keto HMG-CoA reductase inhibitors
|
DE68914495T2
(de)
*
|
1988-03-02 |
1994-10-27 |
Merck & Co Inc |
Antihypercholesterolemisches Mittel.
|
US6545040B1
(en)
|
1988-03-23 |
2003-04-08 |
Janssen Pharmaceutica N.V. |
Method of lowering the blood pressure
|
US4920109A
(en)
*
|
1988-04-18 |
1990-04-24 |
Merck & Co., Inc. |
Antifungal compositions and method of controlling mycotic infections
|
US5166171A
(en)
*
|
1988-05-13 |
1992-11-24 |
Hoechst Aktiengesellschaft |
6-phenoxymethyl-4-hydroxytetrahydropyran-2-ones and 6-thiphenoxymethyl-4-hydroxytetrahydropyran-2-ones and the corresponding dihydroxycarboxylic acid derivatives, salts and esters, and in treating hypercholesterolemia
|
US5036053A
(en)
*
|
1988-05-27 |
1991-07-30 |
Warner-Lambert Company |
Diol-containing renin inhibitors
|
US4897402A
(en)
*
|
1988-06-29 |
1990-01-30 |
Merck & Co., Inc. |
5-oxa, 5-thia, 5-aza HmG-CoA reductase inhibitors
|
US4963538A
(en)
*
|
1988-06-29 |
1990-10-16 |
Merck & Co., Inc. |
5-oxygenated HMG-CoA reductase inhibitors
|
IT1226726B
(it)
*
|
1988-07-29 |
1991-02-05 |
Zambon Spa |
Composti attivi come inibitori della biosintesi del colesterolo.
|
US5196440A
(en)
*
|
1988-07-29 |
1993-03-23 |
Zambon Group S.P.A. |
Compounds active as inhibitors of the cholesterol biosynthesis
|
DE3832570A1
(de)
*
|
1988-09-24 |
1990-03-29 |
Hoechst Ag |
7-substituierte derivate der 3,5-dihydroxyhept-6-insaeure, verfahren zur ihrer herstellung, ihre verwendung als arzneimittel, sowie zwischenprodukte
|
DE3841520A1
(de)
*
|
1988-12-09 |
1990-06-13 |
Hoechst Ag |
Enzymhemmende harnstoffderivate von dipeptiden, verfahren zu ihrer herstellung, diese enthaltende mittel und ihre verwendung
|
US4950675A
(en)
*
|
1988-12-21 |
1990-08-21 |
Warner-Lambert Company |
Pyridine di-mevalono-lactones as inhibitors of cholesterol biosynthesis
|
US4906657A
(en)
*
|
1988-12-21 |
1990-03-06 |
Warner-Lambert Company |
Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
|
US4957940A
(en)
*
|
1988-12-21 |
1990-09-18 |
Warner-Lambert Company |
Bicyclo heptane and bicyclo octane substituted inhibitors of cholesterol synthesis
|
US5106835A
(en)
*
|
1988-12-27 |
1992-04-21 |
American Cyanamid Company |
Renin inhibitors
|
US4923861A
(en)
*
|
1989-02-07 |
1990-05-08 |
Warner-Lambert Company |
6-(2-(2-(Substituted amino)-3-quinolinyl) ethenyl and ethyl) tetrahydro-4-hydroxypyran-2-one inhibitors of cholesterol biosynthesis
|
US5130306A
(en)
*
|
1989-03-13 |
1992-07-14 |
Merck & Co., Inc. |
5-Oxygenated HMG-COA reductase inhibitors
|
US5132312A
(en)
*
|
1989-03-27 |
1992-07-21 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Substituted cyclohexene derivatives as HMG-CoA reductase inhibitors
|
DE4004820A1
(de)
*
|
1989-08-05 |
1991-04-25 |
Bayer Ag |
Renininhibitoren, verfahren zur herstellung und ihre verwendung in arzneimitteln
|
US5064825A
(en)
*
|
1989-06-01 |
1991-11-12 |
Merck & Co., Inc. |
Angiotensin ii antagonists
|
US5102911A
(en)
*
|
1989-06-09 |
1992-04-07 |
Merck & Co, Inc. |
4-Substituted HMG-CoA reductase inhibitors
|
US4970231A
(en)
*
|
1989-06-09 |
1990-11-13 |
Merck & Co., Inc. |
4-substituted HMG-CoA reductase inhibitors
|
US5063208A
(en)
*
|
1989-07-26 |
1991-11-05 |
Abbott Laboratories |
Peptidyl aminodiol renin inhibitors
|
US4992429A
(en)
*
|
1989-08-24 |
1991-02-12 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Novel HMG-COA reductase inhibitors
|
US5098931A
(en)
*
|
1989-08-31 |
1992-03-24 |
Merck & Co., Inc. |
7-substituted HMG-CoA reductase inhibitors
|
US5098924A
(en)
*
|
1989-09-15 |
1992-03-24 |
E. R. Squibb & Sons, Inc. |
Diol sulfonamide and sulfinyl renin inhibitors
|
US5104869A
(en)
*
|
1989-10-11 |
1992-04-14 |
American Cyanamid Company |
Renin inhibitors
|
US4946860A
(en)
*
|
1989-11-03 |
1990-08-07 |
Rorer Pharmaceutical Corporation |
Benzothiopyranyl derivatives as HMG-CoA reductase inhibitors
|
US5114937A
(en)
*
|
1989-11-28 |
1992-05-19 |
Warner-Lambert Company |
Renin inhibiting nonpeptides
|
IT1237793B
(it)
*
|
1989-12-21 |
1993-06-17 |
Zambon Spa |
Composti attivi come inibitori dell'enzima hmg-coa reduttasi
|
US5025000A
(en)
*
|
1990-03-02 |
1991-06-18 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing HMG-CoA reductase inhibitor compounds
|
US5095119A
(en)
*
|
1990-03-08 |
1992-03-10 |
American Home Products Corporation |
Renin inhibitors
|
US5064965A
(en)
*
|
1990-03-08 |
1991-11-12 |
American Home Products Corporation |
Renin inhibitors
|
US5622985A
(en)
*
|
1990-06-11 |
1997-04-22 |
Bristol-Myers Squibb Company |
Method for preventing a second heart attack employing an HMG CoA reductase inhibitor
|
US5085992A
(en)
*
|
1990-07-19 |
1992-02-04 |
Merck & Co., Inc. |
Microbial transformation process for antihypertensive products
|
US5112857A
(en)
*
|
1990-09-04 |
1992-05-12 |
Merck & Co., Inc. |
Hmg-coa reductase inhibitor metabolites
|
US5087634A
(en)
*
|
1990-10-31 |
1992-02-11 |
G. D. Searle & Co. |
N-substituted imidazol-2-one compounds for treatment of circulatory disorders
|
US5071837A
(en)
*
|
1990-11-28 |
1991-12-10 |
Warner-Lambert Company |
Novel renin inhibiting peptides
|
US5182298A
(en)
*
|
1991-03-18 |
1993-01-26 |
Merck & Co., Inc. |
Cholesterol lowering agents
|
US5256689A
(en)
*
|
1991-05-10 |
1993-10-26 |
Merck & Co., Inc. |
Cholesterol lowering compounds
|
US5135935A
(en)
*
|
1991-05-17 |
1992-08-04 |
Merck & Co., Inc. |
Squalene synthetase inhibitors
|
US5250435A
(en)
*
|
1991-06-04 |
1993-10-05 |
Merck & Co., Inc. |
Mutant strains of Aspergillus terreus for producing 7-[1,2,6,7,8,8a(R)-hexa-hydro-2(S),6(R)-dimethyl-8(S)-hydroxy-1(S)-naphthyl]-3(R),5(R)-dihydroxyheptanoic acid (triol acid),I)
|
US5202327A
(en)
*
|
1991-07-10 |
1993-04-13 |
E. R. Squibb & Sons, Inc. |
Phosphorus-containing hmg-coa reductase inhibitors
|
HU217629B
(hu)
*
|
1991-12-12 |
2000-03-28 |
Novartis Ag. |
Eljárás fluvasztatint tartalmazó stabilizált gyógyszerkészítmények előállítására
|
US5260332A
(en)
*
|
1992-02-07 |
1993-11-09 |
Merci & Co., Inc. |
Cholesterol lowering compounds
|
US5262435A
(en)
*
|
1992-02-10 |
1993-11-16 |
Merck & Co., Inc. |
Cholesterol lowering compounds
|
US5286895A
(en)
*
|
1992-02-19 |
1994-02-15 |
Merck & Co., Inc. |
Cholesterol lowering compounds
|
US5302604A
(en)
*
|
1992-03-09 |
1994-04-12 |
Merck & Co., Inc. |
Cholesterol lowering compounds produced by directed biosynthesis
|
US5369125A
(en)
*
|
1992-07-17 |
1994-11-29 |
Merck & Co., Inc. |
Cholesterol-lowering agents
|
US5283256A
(en)
*
|
1992-07-22 |
1994-02-01 |
Merck & Co., Inc. |
Cholesterol-lowering agents
|
US5317031A
(en)
*
|
1992-10-19 |
1994-05-31 |
Merck & Co., Inc. |
Cholesterol lowering compounds
|
US5543297A
(en)
*
|
1992-12-22 |
1996-08-06 |
Merck Frosst Canada, Inc. |
Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity
|
TW355683B
(en)
*
|
1994-02-17 |
1999-04-11 |
Janssen Pharmaceutica Nv |
Composition containing micronized nebivolol
|
KR100264348B1
(ko)
|
1994-12-28 |
2000-08-16 |
디르크 반테 |
항-죽종형성제로서 네비볼롤을 함유하는 조성물
|
US20010044584A1
(en)
*
|
1997-08-28 |
2001-11-22 |
Kensey Kenneth R. |
In vivo delivery methods and compositions
|
US5922341A
(en)
*
|
1997-10-28 |
1999-07-13 |
Vivus, Incorporated |
Local administration of pharmacologically active agents to treat premature ejaculation
|
US6228864B1
(en)
*
|
1997-10-28 |
2001-05-08 |
Vivus, Inc. |
Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
|
US6541479B1
(en)
|
1997-12-02 |
2003-04-01 |
Massachusetts College Of Pharmacy |
Calcium channel blockers
|
US6136804A
(en)
*
|
1998-03-13 |
2000-10-24 |
Merck & Co., Inc. |
Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
|
WO2001017528A1
(en)
|
1999-09-08 |
2001-03-15 |
Nitromed, Inc. |
Methods of treating and preventing congestive heart failure with hydralazine compounds and isosorbide dinitrate or isosorbide mononitrate
|
US7708989B2
(en)
|
1999-10-29 |
2010-05-04 |
Nitromed, Inc. |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
US7235237B2
(en)
|
1999-10-29 |
2007-06-26 |
Nitromed, Inc. |
Methods of treating vascular diseases characterized by nitric oxide insufficiency
|
JP2003514020A
(ja)
|
1999-10-29 |
2003-04-15 |
ニトロメド インコーポレーテッド |
酸化窒素不足により特徴付けられる血管疾患の治療法
|
US20050074487A1
(en)
*
|
1999-12-16 |
2005-04-07 |
Tsung-Min Hsu |
Transdermal and topical administration of drugs using basic permeation enhancers
|
GB9930688D0
(en)
|
1999-12-24 |
2000-02-16 |
Smithkline Beecham Plc |
Novel method of treatment
|
AU780205B2
(en)
*
|
2000-02-23 |
2005-03-10 |
Alteon Inc. |
Thiazolium compounds and treatments of disorders associated with protein aging
|
GB2361185A
(en)
|
2000-04-10 |
2001-10-17 |
Nicholas J Wald |
Pharmaceutical formulation for the prevention of cardiovascular disease
|
US20030176426A1
(en)
|
2000-07-13 |
2003-09-18 |
Alteon, Inc. |
Method for treating fibrotic diseases or other indications with imidazolium agents
|
MXPA03000388A
(es)
|
2000-07-13 |
2003-09-25 |
Alteon Inc |
Metodo para tratar enfermedades fibroticas u otras indicaciones ic.
|
ES2265437T3
(es)
|
2000-07-27 |
2007-02-16 |
Pharmacia Corporation |
Terapia de combinacion antagonista epoxi-esteroidal de aldosterona y antagonista beta-adrenergico para tratamiento de la insuficiencia cardiaca congestiva.
|
US6632180B1
(en)
|
2000-09-07 |
2003-10-14 |
John H. Laragh |
Method for evaluating and treating hypertension
|
US6595926B1
(en)
|
2000-09-07 |
2003-07-22 |
John H. Laragh |
Method for evaluating and treating hypertension
|
US6495154B1
(en)
*
|
2000-11-21 |
2002-12-17 |
Vivus Inc. |
On demand administration of clomipramine and salts thereof to treat premature ejaculation
|
IT1320176B1
(it)
|
2000-12-22 |
2003-11-26 |
Nicox Sa |
Dispersioni solide di principi attivi nitrati.
|
HU228915B1
(en)
|
2000-12-28 |
2013-06-28 |
Kissei Pharmaceutical |
Glucopyranosyloxypyrazole derivatives and use thereof
|
WO2002053161A1
(en)
*
|
2000-12-29 |
2002-07-11 |
Alteon, Inc. |
Method for treating fibrotic diseases or other indications
|
JP2004525904A
(ja)
|
2000-12-29 |
2004-08-26 |
アルテオン インコーポレイテッド |
線維性疾患又は他の適応症iiicの治療方法
|
EP1359911A2
(de)
|
2000-12-29 |
2003-11-12 |
Alteon, Inc. |
Behandlungsmethode von fibrotischen erkrankungen und anderen symptomen vom typ ivc
|
KR100596257B1
(ko)
*
|
2001-01-26 |
2006-07-03 |
쉐링 코포레이션 |
스테롤 흡수 억제제를 포함하는 조성물, 및 페록시솜 증식인자-활성화 수용체 활성화제와 스테롤 흡수 억제제를 포함하는 조성물 및 조합물
|
CN1658903A
(zh)
|
2001-01-26 |
2005-08-24 |
先灵公司 |
用于治疗血管性疾病的固醇吸收抑制剂与血液调节剂的组合
|
US20020183305A1
(en)
|
2001-01-26 |
2002-12-05 |
Schering Corporation |
Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
|
BR0206644A
(pt)
|
2001-01-26 |
2004-02-25 |
Schering Corp |
Combinações de inibidor(es) de absorção de esteróis com agente(s) cardiovascular(es) para o tratamento de condições vasculares
|
US7071181B2
(en)
*
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
KR100820983B1
(ko)
*
|
2001-01-26 |
2008-04-10 |
쉐링 코포레이션 |
치환된 아제티딘온 화합물을 포함하는 약제학적 조성물
|
ATE369851T1
(de)
|
2001-01-26 |
2007-09-15 |
Schering Corp |
Kombinationen von gallensäuresequestriermitteln und hemmern der sterolabsorption zur behandlung von kardiovaskulären indikationen
|
DE60230591D1
(de)
*
|
2001-02-26 |
2009-02-12 |
Kissei Pharmaceutical |
Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
|
DE60233140D1
(de)
*
|
2001-05-02 |
2009-09-10 |
Nitromed Inc |
Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
|
AR038956A1
(es)
*
|
2001-05-25 |
2005-02-02 |
Schering Corp |
Uso de un compuesto que regula la produccion o niveles de peptidos beta amiloides para la manufactura de un medicamento para tratar la enfermedad de alzheimer y/o para regular dichos niveles de peptidos amiloides beta en un sujeto
|
US20030078190A1
(en)
*
|
2001-05-25 |
2003-04-24 |
Weinberg Marc S. |
Methods for tissue protection using highly effective inhibition of the renin-angiotensin system
|
WO2002096362A2
(en)
*
|
2001-05-30 |
2002-12-05 |
Alteon Inc. |
Method for treating fibrotic diseases or other indications vi
|
CA2448741C
(en)
|
2001-05-30 |
2010-06-22 |
Kissei Pharmaceutical Co., Ltd. |
Glucopyranosyloxypyrazole derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
|
CA2448306A1
(en)
|
2001-05-30 |
2002-12-05 |
Alteon Inc. |
Method for treating fibrotic diseases or other indications
|
WO2003000712A1
(fr)
|
2001-06-20 |
2003-01-03 |
Kissei Pharmaceutical Co., Ltd. |
Derive heterocyclique azote, composition medicinale contenant ce derive, leur utilisation medicinale et intermediaire associe
|
CA2460340C
(en)
|
2001-09-21 |
2011-02-15 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of xanthoma using sterol absorption inhibitors
|
US7053080B2
(en)
*
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
US7056906B2
(en)
*
|
2001-09-21 |
2006-06-06 |
Schering Corporation |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
|
US20030119808A1
(en)
|
2001-09-21 |
2003-06-26 |
Schering Corporation |
Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
|
MXPA04002572A
(es)
*
|
2001-09-21 |
2004-05-31 |
Schering Corp |
Metodos para el tratamiento o prevencion de inflamacion vascular usando inhibidores de absorcion de esterol.
|
FR2830856B1
(fr)
*
|
2001-10-15 |
2004-07-30 |
Pechiney Aluminium |
Precurseur de revetement et procede pour revetir un substrat d'une couche refractaire
|
US20030162824A1
(en)
*
|
2001-11-12 |
2003-08-28 |
Krul Elaine S. |
Methods of treating or preventing a cardiovascular condition using a cyclooxygenase-1 inhibitor
|
AU2003240670A1
(en)
*
|
2002-05-17 |
2003-12-02 |
Novartis Ag |
Combination of angiotensin ii receptor blocker and beta-blocker for secondary prevention of myocardial infarction
|
WO2003097011A1
(en)
*
|
2002-05-17 |
2003-11-27 |
Eisai Co., Ltd. |
Compositions and methods using proton pump inhibitors
|
US7105526B2
(en)
|
2002-06-28 |
2006-09-12 |
Banyu Pharmaceuticals Co., Ltd. |
Benzimidazole derivatives
|
GB0215579D0
(en)
*
|
2002-07-05 |
2002-08-14 |
Astrazeneca Ab |
Chemical compounds
|
WO2004011440A1
(ja)
|
2002-07-30 |
2004-02-05 |
Banyu Pharmaceutical Co., Ltd. |
ベンズイミダゾール誘導体を有効成分とするメラニン凝集ホルモン受容体拮抗剤
|
JP4667867B2
(ja)
|
2002-08-02 |
2011-04-13 |
メルク・シャープ・エンド・ドーム・コーポレイション |
置換フロ[2,3−b]ピリジン誘導体
|
MXPA05001549A
(es)
|
2002-08-08 |
2005-05-05 |
Kissei Pharmaceutical |
Derivado de pirazol, composicion medicinal que lo contiene, su uso medicinal, e intermediario para su produccion.
|
JP2004137245A
(ja)
|
2002-08-23 |
2004-05-13 |
Kissei Pharmaceut Co Ltd |
ピラゾール誘導体、それを含有する医薬組成物、その医薬用途及びその製造中間体
|
US6869966B2
(en)
|
2002-09-30 |
2005-03-22 |
Banyu Pharmaceutical Co., Ltd. |
N-substituted-2-oxodihydropyridine derivatives
|
AU2003272903A1
(en)
|
2002-10-04 |
2004-04-23 |
Kissei Pharmaceutical Co., Ltd. |
Pyrazole derivative, medicinal composition containing the same, medicinal use thereof and intermediate in producing the same
|
EP1566384B1
(de)
*
|
2002-11-29 |
2009-06-17 |
Banyu Pharmaceutical Co., Ltd. |
Neue azolderivate
|
US7670627B2
(en)
|
2002-12-09 |
2010-03-02 |
Salvona Ip Llc |
pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
|
US20050031651A1
(en)
*
|
2002-12-24 |
2005-02-10 |
Francine Gervais |
Therapeutic formulations for the treatment of beta-amyloid related diseases
|
JPWO2004069798A1
(ja)
*
|
2003-02-10 |
2006-05-25 |
萬有製薬株式会社 |
ピペリジン誘導体を有効成分とするメラニン凝集ホルモン受容体拮抗剤
|
ATE418551T1
(de)
|
2003-03-07 |
2009-01-15 |
Schering Corp |
Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
|
CA2517573C
(en)
|
2003-03-07 |
2011-12-06 |
Schering Corporation |
Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
|
DE602004016123D1
(de)
*
|
2003-03-07 |
2008-10-09 |
Schering Corp |
Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
|
JP4408197B2
(ja)
*
|
2003-04-07 |
2010-02-03 |
パイオニア株式会社 |
表示画面の焼付防止装置及び焼付防止方法
|
MXPA05010945A
(es)
|
2003-04-09 |
2005-11-25 |
Japan Tobacco Inc |
Compuesto pentaciclico heteroaromatico y uso medicinal del mismo.
|
US7501405B2
(en)
*
|
2003-04-11 |
2009-03-10 |
High Point Pharmaceuticals, Llc |
Combination therapy using an 11β-hydroxysteroid dehydrogenase type 1 inhibitor and an antihypertensive agent for the treatment of metabolic syndrome and related diseases and disorders
|
US7700583B2
(en)
*
|
2003-04-11 |
2010-04-20 |
High Point Pharmaceuticals, Llc |
11β-hydroxysteroid dehydrogenase type 1 active compounds
|
US20060094699A1
(en)
|
2003-04-11 |
2006-05-04 |
Kampen Gita Camilla T |
Combination therapy using an 11beta-hydroxysteroid dehydrogenase type 1 inhibitor and a glucocorticoid receptor agonist to minimize the side effects associated with glucocorticoid receptor agonist therapy
|
WO2004089380A2
(en)
*
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
Pharmaceutical use of fused 1,2,4-triazoles
|
US20060100235A1
(en)
*
|
2003-04-11 |
2006-05-11 |
Novo Nordisk A/S |
Pharmaceutical use of substituted 1,2,4-triazoles
|
US20050014747A1
(en)
*
|
2003-04-18 |
2005-01-20 |
Emily Reinhard |
Dihydrothiazine prodrugs of thiazolium agents
|
EP1635813A4
(de)
*
|
2003-06-06 |
2009-07-01 |
Merck & Co Inc |
Kombinationstherapie zur behandlung von dyslipidämie
|
EP1637539B1
(de)
|
2003-06-20 |
2012-01-18 |
Kissei Pharmaceutical Co., Ltd. |
Pyrazolderivat, arzneimittelzusammensetzung, die dieses enthält, und zwischenprodukt für dessen herstellung
|
US20050032879A1
(en)
*
|
2003-08-07 |
2005-02-10 |
Temple Okarter |
Formulations and use of a beta-blocker and an ACE-inhibitor for the treatment of cardiovascular diseases
|
CA2540984C
(en)
*
|
2003-10-10 |
2011-02-08 |
Lifecycle Pharma A/S |
A solid dosage form comprising a fibrate
|
US20050096307A1
(en)
*
|
2003-11-05 |
2005-05-05 |
Schering Corporation |
Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
|
WO2005099699A1
(en)
|
2004-04-07 |
2005-10-27 |
Sepracor Inc. |
Combination of (s)-amlodipine and a beta-blocker, and methods for reducing hypertension
|
US7803838B2
(en)
|
2004-06-04 |
2010-09-28 |
Forest Laboratories Holdings Limited |
Compositions comprising nebivolol
|
US20060014828A1
(en)
*
|
2004-07-16 |
2006-01-19 |
Nitromed, Inc. |
Compositions and methods related to heart failure
|
EP1807070A1
(de)
|
2004-09-29 |
2007-07-18 |
Schering Corporation |
Kombinationen aus substituierten azetidinonen und cb1-antagonisten
|
US20060142288A1
(en)
*
|
2004-12-07 |
2006-06-29 |
Stephen Peroutka |
Combinations and methods for headaches
|